Editorial: interventions in infantile colic - can efficacy be attributed to treatment or to time? Authors' reply

Rita Nocerino^{1

2}, Francesca De Filippis^{3

4}, Gaetano Cecere¹, Antonio Marino¹, Maria Micillo¹, Carmen Di Scala^{1

2}, Carmen de Caro⁵, Antonio Calignano⁵, Cristina Bruno^{1

2}, Lorella Paparo^{1

2}, Anna Maria Iannicelli¹, Linda Cosenza^{1

2}, Ylenia Maddalena^{1

2}, Giusy Della Gatta^{1

2}, Serena Coppola^{1

2}, Laura Carucci^{1

2}, Danilo Ercolini^{3

4}, Roberto Berni Canani^{1

2

4

6}

Affiliations

¹ Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
² CEINGE Advanced Biotechnologies, University of Naples Federico II, Naples, Italy.
³ Department of Agricultural Sciences, University of Naples Federico II, Portici, Italy.
⁴ Task Force on Microbiome Studies, University of Naples Federico II, Naples, Italy.
⁵ Department of Pharmacy, University of Naples Federico II, Naples, Italy.
⁶ European Laboratory for the Investigation of Food-Induced Diseases, University of Naples Federico II, Naples, Italy.

Editorial

Rita Nocerino et al. Aliment Pharmacol Ther. 2020 Feb.

. 2020 Feb;51(3):398-399.

doi: 10.1111/apt.15627.

¹ Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
² CEINGE Advanced Biotechnologies, University of Naples Federico II, Naples, Italy.
³ Department of Agricultural Sciences, University of Naples Federico II, Portici, Italy.
⁴ Task Force on Microbiome Studies, University of Naples Federico II, Naples, Italy.
⁵ Department of Pharmacy, University of Naples Federico II, Naples, Italy.
⁶ European Laboratory for the Investigation of Food-Induced Diseases, University of Naples Federico II, Naples, Italy.

No abstract available

Comment on

The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12^® in infant colic: A randomised, double blind, placebo-controlled trial.
Nocerino R, De Filippis F, Cecere G, Marino A, Micillo M, Di Scala C, de Caro C, Calignano A, Bruno C, Paparo L, Iannicelli AM, Cosenza L, Maddalena Y, Della Gatta G, Coppola S, Carucci L, Ercolini D, Berni Canani R. Nocerino R, et al. Aliment Pharmacol Ther. 2020 Jan;51(1):110-120. doi: 10.1111/apt.15561. Epub 2019 Dec 3. Aliment Pharmacol Ther. 2020. PMID: 31797399 Free PMC article. Clinical Trial.
Editorial: interventions in infantile colic - can efficacy be attributed to treatment or to time?
Iacovou M. Iacovou M. Aliment Pharmacol Ther. 2020 Feb;51(3):397-398. doi: 10.1111/apt.15599. Aliment Pharmacol Ther. 2020. PMID: 31943271 No abstract available.

1. Iacovou M. Editorial: interventions in infantile colic. Can efficacy be attributed to treatment or to time? Aliment PharmacolTher. 2020;in press.
1. Nocerino R, De Filippis F, Cecere G, et al. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic: a randomised, double blind, placebo-controlled trial. Aliment PharmacolTher. 2019;00:1-11. https://doi.org/10.1111/apt.15561
1. Wolke D, Bilgin A, Samara M. Systematic review and meta-analysis: fussing and crying durations and prevalence of colic in infants. J Pediatr. 2017;185:e4.
1. Reijneveld SA, Brugman E, Hirasing RA. Excessive infant crying: the impact of varying definitions. Pediatrics. 2001;108:893-897.
1. Baldassarre M, Di Mauro A, Tafuri S, et al. Effectiveness and safety of a probiotic-mixture for the treatment of infantile colic: a double-blind, randomized, placebo-controlled clinical trial with fecal real-time PCR and NMR-based metabolomics analysis. Nutrients. 2018;10:E195.